N-Cyano Sulfoximines: COX Inhibition, Anticancer Activity, Cellular Toxicity, and Mutagenicity

ChemMedChem

Volumn 8, Issue 2, 2013, Pages 217-220

  Park, Seong Jun ^a   Baars, Hannah ^a   Mersmann, Stefanie ^a   Buschmann, Helmut ^b   Baron, Jens Malte ^c   Amann, Philipp M ^c   Czaja, Katharina ^c   Hollert, Henner ^a   Bluhm, Kerstin ^a   Redelstein, Regine ^a   Bolm, Carsten ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b not available   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cancer; Cyclooxygenases; Cytotoxicity; Inhibitors; N cyano sulfoximines

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; N CYANO SULFOXIMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MUTAGENICITY; PRIORITY JOURNAL;

EID: 84873843984     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201200403     Document Type: Article

References (37)

1. Y. Zhu, M. R. Loso, G. B. Watson, T. C. Sparks, R. B. Rogers, J. X. Huang, B. C. Gerwick, J. M. Babcock, D. Kelley, V. B. Hegde, B. M. Nugent, J. M. Renga, I. Denholm, K. Gorman, G. J. DeBoer, J. Hasler, T. Meade, J. D. Thomas, J. Agric. Food Chem. 2011, 59, 2950;
2. J. M. Babcock, C. B. Gerwick, J. X. Huang, M. R. Loso, G. Nakamura, S. P. Nolting, R. B. Rogers, T. C. Sparks, J. Thomas, G. B. Watson, Y. Zhu, Pest Manage. Sci. 2011, 67, 328;
3. G. B. Watson, M. R. Loso, J. M. Babcock, J. M. Hasler, T. J. Letherer, C. D. Young, Y. Zhu, J. E. Casida, T. C. Sparks, Insect Biochem. Mol. Biol. 2011, 41, 432.
4. For two representative examples from the patent literature, see:
5. Isoxazoline Derivatives and Their Use as Herbicides, A. Plant, J.E. Boehmer, A.L. Peace, (Syngenta Ltd, UK), WO/2006/037945A1, 2006;
6. Multi-substituted Pyridyl Sulfoximines and Their Use as Insecticides, Y. Zhu, M.R. Loso, B.M. Nugent, J.X. Huang, R.B. Rogers, (Dow AgroSciences LLC, Indianapolis, USA), WO/2008/057129A1, 2008.
7. For advanced syntheses of N-cyano sulfoximines, see:
8. O. G. Mancheño, C. Bolm, Org. Lett. 2007, 9, 2951;
9. O. G. Mancheño, O. Bistri, C. Bolm, Org. Lett. 2007, 9, 3809;
10. A. Pandey, C. Bolm, Synthesis 2010, 2922;
11. O. G. Mancheño, J. Dallimore, A. Plant, C. Bolm, Adv. Synth. Catal. 2010, 352, 309.
12. M. Kahraman, S. Sinishtaj, P. M. Dolan, T. W. Kensler, S. Peleg, U. Saha, S. S. Chuang, G. Bernstein, B. Korczak, G. H. Posner, J. Med. Chem. 2004, 47, 6854;
13. A. Raza, Y. Y. Sham, R. Vince, Bioorg. Med. Chem. Lett. 2008, 18, 5406;
14. D. P. Walker, M. P. Zawistoski, M. A. McGlynn, J.-C. Li, D. W. Kung, P. C. Bonnette, A. Baumann, L. Buckbinder, J. A. Houser, J. Boer, A. Mistry, S. Han, L. Xing, A. Guzman-Perez, Bioorg. Med. Chem. Lett. 2009, 19, 3253;
15. K. Takahashi, R. Tatsunami, T. Oba, Y. Tampo, Biol. Pharm. Bull. 2010, 33, 556;
16. G. Siemeister, U. Lücking, A. M. Wengner, P. Lienau, W. Steinke, C. Schatz, D. Mimberg, K. Ziegelbauer, Mol. Cancer Ther. 2012, 11, 2265.
17. S. J. Park, H. Buschmann, C. Bolm, Bioorg. Med. Chem. Lett. 2011, 21, 4888.
18. For a related study demonstrating COX inhibition and estrogen receptor binding of sulfoximines with a triaryl olefin core, see: X. Y. Chen, S. J. Park, H. Buschmann, M. DeRosa, C. Bolm, Bioorg. Med. Chem. Lett. 2012, 22, 4307.
19. 50 values are given in the Supporting Information.
20. Compounds 3-6 are analogues of known sulfone-based COX inhibitors. Compound 3:
21. W. C. Black, C. Brideau, C. C. Chan, S. Charleson, N. Chauret, D. Claveau, D. Ethier, R. Gordon, G. Greig, J. Guay, G. Hughes, P. Jolicoeur, Y. Leblanc, D. Nicoll-Griffith, N. Ouimet, D. Riendeau, D. Visco, Z. Wang, L. Xu, P. Prasit, J. Med. Chem. 1999, 42, 1274; Compound 4:
22. R. W. Friesen, C. Brideau, C. C. Chan, S. Charleson, D. Deschênes, D. Dubé, D. Ethier, R. Fortin, J. Y. Gauthier, Y. Girard, R. Gordon, G. M. Greig, D. Riendeau, C. Savoie, Z. Wang, E. Wong, D. Visco, L. J. Xu, R. N. Young, Bioorg. Med. Chem. Lett. 1998, 8, 2777; Compound 5:
23. 5-Arylpyrazole Compounds, K. Nakamura, T. Terasaka, T. Ogino, Y. Noda, T. Manabe, (Fujisawa Pharmaceuticals Co. Ltd, Osaka, Japan), WO/1999/25695A1, 1999;
24. In analogy to celecoxib as reported in T. D. Penning, J. J. Talley, S. R. Bertenshaw, J. S. Carter, P. W. Collins, S. Docter, M. J. Graneto, L. F. Lee, J. W. Malecha, J. M. Miyashiro, R. S. Rogers, D. J. Rogier, S. S. Yu, G. D. Anderson, E. G. Burton, J. N. Cogburn, S. A. Gregory, C. M. Koboldt, W. E. Perkins, K. Seibert, A. W. Veenhuizen, Y. Y. Zhang, P. C. Isakson, J. Med. Chem. 1997, 40, 1347; Compound 6:
25. K. R. Gans, W. Galbraith, R. J. Roman, S. B. Haber, J. S. Kerr, W. K. Schmidt, C. Smith, W. E. Hewes, N. R. Ackerman, J. Pharmacol. Exp. Ther. 1990, 254, 180.
26. Experimental details and analytical data for all products are given in the Supporting Information.
27. Because enantiopure 6 was noncrystalline, the absolute configuration was assigned by comparing calculated and measured electronic circular dichroism (ECD) spectra. Unfortunately, significant peak shifts and signal fluctuations were observed, allowing only tentative data interpretation. Accordingly, compounds 6-A and 6-B are believed to have the R and S configuration, respectively. For details, see the Supporting Information.
28. M. N. A. Khan, Y. S. Lee, Med. Res. Rev. 2011, 31, 161;
29. L. J. Marnett, J. Org. Chem. 2012, 77, 5224.
30. Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, US National Cancer Institute (NCI)/National Institutes of Health (NIH); http://dtp.cancer.gov.
31. All one-dose-mean graphs for compounds 2c, 3-6 and the five-dose-response curve for compound 6 are presented in the Supporting Information.
32. P. Boukamp, R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, N. E. Fusenig, J. Cell. Biol. 1988, 106, 761.
33. P. Jeschke in Modern Crop Protection Compounds, 2nded., (Eds.: W. Krämer, U. Schirmer, P. Jeschke, M. Witschel), Wiley-VCH, Weinheim, 2011, pp.1231;
34. Joint United Nations Food and Agriculture Organization (FAO)/World Health Organization (WHO) Meeting on Pesticide Residues (JMPR), report no. 252, 2011 (available here: http://www.fao.org/publications/en/).
35. G. Reifferscheid, H. M. Maes, B. Allner, J. Badurova, S. Belkin, K. Bluhm, F. Brauer, J. Bressling, S. Domeneghetti, T. Elad, S. Flückinger-Isler, H. J. Grummt, R. Gürtler, A. Hecht, M. B. Heringa, H. Hollert, S. Huber, M. Kramer, A. Magdeburg, H. T. Ratte, R. Sauerborn-Klobucar, A. Sokolowski, P. Soldan, T. Smital, D. Stalter, P. Venier, C. Ziemann, J. Zipperle, S. Buchinger, Environ. Mol. Mutagen. 2012, 53, 185.
36. Water quality-Determination of the genotoxicity of water and wastewater using the Salmonella/microsome fluctuation test (Ames fluctuation test), International Standards Organization (ISO), document no. ISO11350, 2012.
37. For test principles and experimental details, see the Supporting Information.